Variant report
Variant | nsv963913 |
---|---|
Chromosome Location | chr2:53375805-53380789 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs376856069 | chr2:53375816-53375817 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs12616144 | chr2:53375820-53375821 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs568613942 | chr2:53375832-53375833 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79527634 | chr2:53375857-53375858 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs141479226 | chr2:53375877-53375878 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12612804 | chr2:53375897-53375898 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs566032722 | chr2:53375941-53375942 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs150389765 | chr2:53375945-53375946 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550728305 | chr2:53375983-53375984 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs548581051 | chr2:53376004-53376005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs386646160 | chr2:53376010-53376011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11125473 | chr2:53376012-53376013 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs553603057 | chr2:53376017-53376018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189893690 | chr2:53376059-53376060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577323505 | chr2:53376092-53376093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183186942 | chr2:53376110-53376111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10171983 | chr2:53376125-53376126 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs374422976 | chr2:53376150-53376151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571802863 | chr2:53376155-53376156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188642973 | chr2:53376195-53376196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560529007 | chr2:53376219-53376220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574408175 | chr2:53376258-53376259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs367676077 | chr2:53376326-53376327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192387029 | chr2:53376328-53376329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555531082 | chr2:53376385-53376386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs199528151 | chr2:53376420-53376421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532291498 | chr2:53376421-53376422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574238689 | chr2:53376425-53376426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552085299 | chr2:53376471-53376472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559826186 | chr2:53376531-53376532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368316069 | chr2:53376564-53376565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs11892805 | chr2:53376578-53376579 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs12185582 | chr2:53376615-53376616 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs143876124 | chr2:53376633-53376634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531236970 | chr2:53376668-53376669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551217131 | chr2:53376669-53376670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375866772 | chr2:53376687-53376688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543481584 | chr2:53376689-53376690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147324856 | chr2:53376740-53376741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs11892855 | chr2:53376742-53376743 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs139379065 | chr2:53376752-53376753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs565469399 | chr2:53376777-53376778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188706513 | chr2:53376795-53376796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs554165404 | chr2:53376815-53376816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574047021 | chr2:53376843-53376844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543360100 | chr2:53376857-53376858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79661060 | chr2:53376869-53376870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369835663 | chr2:53376877-53376878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544658714 | chr2:53376922-53376923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs143194193 | chr2:53376942-53376943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:53375600-53376000 | Enhancers | Fetal Lung | lung |
2 | chr2:53375800-53376000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
3 | chr2:53376000-53383800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr2:53380600-53381200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |